Prasanna Sivaprakasam Selected Research

Mood Disorders (Mood Disorder)

1/2023	Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-b]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors.
2/2016	Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Prasanna Sivaprakasam Research Topics

Disease

6	Neoplasms (Cancer) 02/2024 - 05/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2006
2	Mood Disorders (Mood Disorder) 01/2023 - 02/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2015 - 09/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Infections 12/2020
1	Virus Diseases (Viral Diseases) 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Stroke (Strokes) 05/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2015
1	Amyloid Plaque 12/2006
1	Malaria 11/2006

Drug/Important Bio-Agent (IBA)

4	Glycogen Synthase Kinase 3IBA 01/2023 - 05/2015
2	tau Proteins (tau Protein)IBA 01/2023 - 01/2023
2	Human immunodeficiency virus 1 p31 integrase proteinIBA 12/2020 - 11/2020
2	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
2	Glycogen Synthase (Synthase I)IBA 05/2015 - 12/2006
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2024
1	BenzodiazepinesIBA 11/2020
1	1,2,3,4-tetrahydroisoquinolineIBA 11/2020
1	pyridineIBA 11/2020
1	uncialamycinIBA 01/2019
1	MesothelinIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 09/2014
1	tau-protein kinaseIBA 09/2014

Therapy/Procedure

2	Therapeutics 01/2019 - 11/2006
1	Immunotherapy 02/2024
1	Highly Active Antiretroviral Therapy (HAART) 12/2020